$PLBC

Plumas Bancorp price target lowered to $59 from $61 at Piper Sandler

Piper Sandler has decreased its price target for Plumas Bancorp (PLBC) to $59 from $61, while maintaining an Overweight rating on the shares. This adjustment is part of broader changes to their Western bank coverage estimates and price targets, aligning with their Q1 preview for Regional & Community Banks.

Original reporting
Published Apr 3, 2026, 3:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 3, 2026, 4:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$PLBC
Neutral
medium confidence
Mentioned
$PLBC
alphai data visualization · based on TipRanks
Decision brief

The 30-second read

$PLBCNeutralLow
01

Why it matters

The revision indicates cautious outlook but does not suggest immediate deterioration in PLBC's fundamentals.

02

Market read

The news is primarily relevant to investors holding or considering positions in PLBC or similar regional banks, with limited broader market impact.

03

What to watch

The overall health of PLBC's loan portfolio and regional economic indicators could offset negative sentiment from the target revision.

Timing: short-term (within days to weeks)

Background

Piper Sandler's adjustment is part of their broader review of Western regional banks, possibly reflecting sector-wide concerns or valuation adjustments.

Company-level read

Ticker impact

$PLBCNeutralMedium confidence
Context

The news pertains directly to Plumas Bancorp (PLBC), with a specific price target adjustment by Piper Sandler.

Expected impact

Potential short-term price decline of approximately 2-3% due to the lowered target, but overall neutral impact given the maintained rating.

Evidence & confidence

The price target reduction is modest and accompanied by an unchanged rating, suggesting limited immediate impact. Market reaction will depend on investor perception of the broader coverage adjustments.

Market effects

Possible slight negative sentiment towards regional banks in the Western US.

Limited, primarily affecting investors focused on PLBC or regional banking sector.

negligible

Counterpoint

The price target reduction may be a conservative move; actual fundamentals could support stable or rising prices if broader economic conditions remain favorable.

Key entities

  • Plumas Bancorp

    A regional bank operating in the Western United States.

  • Piper Sandler

    An investment bank and financial services firm providing research and analysis.

Related articles

$PLBCMedAI 8/10

Plumas Bancorp Reports Record Second Quarter 2026 Earnings

Plumas Bancorp (Nasdaq:PLBC) reported record Q2 2026 net income of $9.9 million, or $1.43 per share, up from $6.3 million, or $1.07 per share in Q2 2025. Net interest income rose to $26.0 million, credit loss provision fell to $600k, and deposits and loans grew after its Cornerstone acquisition. Six-month net income increased to $19.7 million.

$PLBCMed

PLUMAS BANCORP (PLBC): Results of Operations and Financial Condition

PLUMAS BANCORP (PLBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_987726.htm EXHIBIT 99.1 ex_987726.htm Exhibit 99.1 PLUMAS BANCORP REPORTS RECORD SECOND QUARTER 2026 EARNINGS Reno, Nevada, July 15, 2026 – Plumas Bancorp (Nasdaq:PLBC) referred to herein as the ‘Company,’ the parent company of Plumas Bank, today announced record ear

$PLBCMed

Plumas Bancorp (NASDAQ:PLBC) Share Price Crosses Above 200

Plumas Bancorp (NASDAQ:PLBC) shares rose above their 200-day moving average on Wednesday, trading up to $53.21 and last at $52.84. The stock has a 200-day average near $48.40. Analysts cited include Stephens raising its target to $60 and Piper Sandler to $63. In April 15 earnings, PLBC reported $1.38 EPS and $28.14M revenue.

$JNJMedAI 8/10

Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Johnson & Johnson (JNJ) proposed a $5.5B settlement for 76,000 talc-related lawsuits, but it requires 95% claimant approval and may exceed this amount. The company has $21B in cash and expects to pay $3B in 2027, with further payments starting in 2028. A judge's recent ruling may strengthen JNJ's legal position. Investors weigh the benefit of reduced uncertainty against potential higher costs.

$CRWDMed

Analysts Back CrowdStrike, Dell and SanDisk Growth

Wall Street analysts maintain positive outlooks on CrowdStrike, Dell, and SanDisk, citing long-term growth in cybersecurity, AI infrastructure, and storage. CrowdStrike's price target raised to $245 by Truist, Dell's to $550 by Evercore, and SanDisk's to $2,250 by J.P. Morgan, all with buy ratings.

$PBRMed

Pemex and Petrobras Bet Big on High-Risk High-Reward Drilling Off Mexico

Pemex and Petrobras are collaborating to explore deep, high-risk oil prospects in the Gulf of Mexico. Pemex, facing declining production and high debt, seeks to unlock potential resources in Jurassic formations. Petrobras, with extensive pre-salt drilling experience, brings technical expertise. Success could reverse Pemex's fortunes, but risks remain high. Pemex reported a 70% net profit drop in Q2 2024, producing 1.66 million bpd, below government targets.